Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate hearing later this year to defend the pricing of the group’s semaglutide-based therapies for diabetes ...

(Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S. prices ...

The vote that was scheduled for next week was preempted with the announcement that Novo Nordisk CEO Lars Fruergaard Jørgensen had agreed to testify before the Senate Health, Education, Labor and ...

Novo Nordisk CEO Lars Fruergaard Jorgensen has agreed to face questions at a Senate hearing in September after Sen. Bernie Sanders, I-Vermont, threatened to subpoena the company over its pricing ...

When told by Sanders that the three leading PBMs had agreed to not reduce access to Ozempic and Wegovy should Novo Nordisk substantially cut the cost, the executive said he'd be open to ...

WASHINGTON — Sen. Bernie Sanders, I-Vt., on Tuesday extracted a meager commitment from Novo Nordisk CEO Lars Fruergaard Jørgensen to meet with pharmacy benefits managers to discuss lowering the ...

Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy.Chairman Sen. Bernie Sanders, I-Vt ...

Sen. Bernie Sanders (I-Vt.) on Friday dropped his pursuit of a subpoena for a top pharmaceutical executive after the company’s CEO agreed to testify before the Senate later this year. Sanders ...

(Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a hearing focusing on U.S. prices ...

Novo responded with a letter in May blaming the U.S. health system for the high prices, according to a report. Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy View ...

Sen. Bernie Sanders (I-Vt.) on Friday dropped his pursuit of a subpoena for a top pharmaceutical executive after the company’s CEO agreed to testify before the Senate later this year. Sanders ...